These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 849085)

  • 41. [Treatment of paroxysmal nocturnal hemoglobinuria with antilymphocyte globulin].
    Sánchez-Valle E; Morales-Polanco MR; Gómez-Morales E; Gutiérrez-Alamillo LI; Gutiérrez-Espíndola G; Pizzuto-Chávez J
    Rev Invest Clin; 1993; 45(5):457-61. PubMed ID: 8134727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paroxysmal nocturnal hemoglobinuria and the transfusion of washed red cells. A myth revisited.
    Brecher ME; Taswell HF
    Transfusion; 1989 Oct; 29(8):681-5. PubMed ID: 2799892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Perioperative management of patients with paroxysmal nocturnal hemoglobinuria.
    Braren V; Jenkins DE; Phythyon JM; Hartmann RC; Clark DA
    Surg Gynecol Obstet; 1981 Oct; 153(4):515-20. PubMed ID: 6169165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo effects of various therapies on complement-sensitive erythrocytes in paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Saitoh Y; Noji H; Terasawa T; Maruyama Y
    Int J Hematol; 1996 Jun; 63(4):291-302. PubMed ID: 8762812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paroxysmal nocturnal hemoglobinuria (PNH) as a clonal disorder.
    Hartmann RC; Arnold AB
    Annu Rev Med; 1977; 28():187-94. PubMed ID: 324358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone marrow failure syndromes: paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):333-46. PubMed ID: 19327587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Erythrocytes of patients with paroxysmal nocturnal haemoglobinuria acquire resistance to complement attack by purified 20-kD homologous restriction factor.
    Okada N; Harada R; Okada H
    Clin Exp Immunol; 1990 Apr; 80(1):109-13. PubMed ID: 1691059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced red blood cell surface level of Factor H as a mechanism underlying paroxysmal nocturnal hemoglobinuria.
    Zhang L; Chen JY; Kerr C; Cobb BA; Maciejewski JP; Lin F
    Leukemia; 2021 Apr; 35(4):1176-1187. PubMed ID: 32814838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aortic valve bypass for aortic stenosis in a patient with paroxysmal nocturnal hemoglobinuria.
    Ghoreishi M; Baer MR; Bhargava R; Stauffer CE; Griffith BP; Gammie JS
    Ann Thorac Surg; 2010 Jul; 90(1):279-81. PubMed ID: 20609796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of erythrocytes deficient in glycosylphosphatidyl-inositol anchored membrane proteins in patients with paroxysmal nocturnal hemoglobinuria by the toxin HEC secreted by Aeromonas hydrophila J-1.
    Wang J; Liu HL; Xu CM; Yang Y; Lv ZJ; Pang HZ; Zhang ZN
    Hematology; 2003 Feb; 8(1):41-6. PubMed ID: 12623426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Periodontal surgery for a patient with paroxysmal nocturnal hemoglobinuria.
    Cohen CI; Zimmerman DR
    J Periodontol; 1988 Feb; 59(2):115-7. PubMed ID: 2964520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful CABG in a patient with paroxysmal nocturnal hemoglobinuria.
    Naito Y; Nakajima M; Inoue H; Tsuchiya K
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):468-70. PubMed ID: 15019684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Young NS; Schubert J; Brodsky RA; Socié G; Muus P; Röth A; Szer J; Elebute MO; Nakamura R; Browne P; Risitano AM; Hill A; Schrezenmeier H; Fu CL; Maciejewski J; Rollins SA; Mojcik CF; Rother RP; Luzzatto L
    N Engl J Med; 2006 Sep; 355(12):1233-43. PubMed ID: 16990386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Abnormality of erythrocyte membrane in paroxysmal nocturnal hemoglobinuria and the physiopathologic condition].
    Abe T
    Nihon Naika Gakkai Zasshi; 1990 May; 79(5):638-41. PubMed ID: 2380609
    [No Abstract]   [Full Text] [Related]  

  • 55. Paroxysmal nocturnal hemoglobinuria. A complement-mediated disease.
    Halperin JA; Nicholson-Weller A
    Complement Inflamm; 1989; 6(1):65-72. PubMed ID: 2650991
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complement-induced procoagulant alteration of red blood cell membranes with microvesicle formation in paroxysmal nocturnal haemoglobinuria (PNH): implication for thrombogenesis in PNH.
    Ninomiya H; Kawashima Y; Hasegawa Y; Nagasawa T
    Br J Haematol; 1999 Jul; 106(1):224-31. PubMed ID: 10444191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):208-216. PubMed ID: 27913482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paroxysmal nocturnal hemoglobinuria: an historical overview.
    Parker CJ
    Hematology Am Soc Hematol Educ Program; 2008; ():93-103. PubMed ID: 19074065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in the terminal steps of complement lysis of normal and paroxysmal nocturnal hemoglobinuria red cells.
    Rouault TA; Rosse WF; Bell S; Shelburne J
    Blood; 1978 Feb; 51(2):325-30. PubMed ID: 620087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the enhanced susceptibility of paroxysmal nocturnal hemoglobinuria erythrocytes to complement-mediated hemolysis initiated by cobra venom factor.
    Parker CJ; Stone OL; Bernshaw NJ
    J Immunol; 1989 Jan; 142(1):208-16. PubMed ID: 2909615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.